RHÖN-KLINIKUM AG

  • WKN: 704230
  • ISIN: DE0007042301
  • Land: Deutschland

Nachricht vom 09.02.2012 | 07:00

RHÖN-KLINIKUM AG: RHÖN-KLINIKUM AG publishes preliminary business figures for full-year 2011


RHÖN-KLINIKUM AG / Key word(s): Forecast/Final Results

09.02.2012 / 07:00

---------------------------------------------------------------------

 Number of treated patients grows by +11.5 % to over 2.2 million
 Revenues climb by +3.0 % to reach EUR 2.63 billion
 Operating EBITDA improves by +9.8 % to EUR 337 million
 Net consolidated profit rises by +11.0 % to EUR 161 million

Bad Neustadt a. d. Saale, 9 February 2012  --------  With its revenue and
earnings figures for financial year 2011 published today, RHÖN-KLINIKUM AG
has clearly performed in line with expectations, comfortably reaching its
stated targets as in the past despite a challenging regulatory environment.
'Last year's growth in patient numbers well into double digit territory
demonstrates impressively our reliable and generalised-coverage medical
care competence as well as the high quality of our medical offering', said
Wolfgang Pföhler, chairman of the Board of Management of RHÖN-KLINIKUM AG.

In 2011, a total of 2,277,000 patients were treated in the Group's
facilities. This translates into growth of 11.5 % compared with the year
before. Revenues rose over the same period by 3.0 % to reach EUR 2.63
billion. During the reporting period, net consolidated profit stood at EUR
161 million, exceeding the figure of the same period in 2010 by 11.0 %. In
2011, operating EBITDA was EUR 337 million, which corresponds to a 9.8 %
rise compared with the previous year. Reported EBITDA was moreover boosted
by a one-off, non-operative extraordinary effect in the amount of EUR 17
million.

'Despite tougher framework conditions and substancial price pressures, we
demonstrated last year that providing high-quality medical care for
everyone can be reconciled to demanding economic objectives within the
German healthcare system. That is something we are proud of. We once again
expect rising demand at our hospitals accompanied by correspondingly
earnings contributions', said Dr. Erik Hamann, CFO at RHÖN-KLINIKUM AG.

'Our high capacity to invest, which is ultimately fed from the surpluses
generated by our hospitals, is what forms the basis of sustainable,
efficient and thus also affordable hospital care. During the past financial
year, for example, we opened new buildings in Gießen, Marburg, Hildesheim,
Erlenbach and Munich. At the same time this is the starting point for our
sound growth course whose core element is the focus on sustainable and
integrated care structures. In this regard we deliberately do away with the
boundaries between hospitals and outpatient care centres in the interest of
meeting the real need of patients, and create the basis for the
patient-oriented, open medical care of tomorrow', adds Wolfgang Pföhler in
conclusion.

Summary of key figures

                2011   2010       Change in %
Patients treated     2,277,153   2,041,782 +11.5 %
Revenues (EUR m)       2,628         2,550           +3.0 %
Operating EBITDA (EUR m) 337   307           +9.8 %
Net consolidated profit (EUR m)161   145           +11.0 %

**************************************************************************
*******

RHÖN-KLINIKUM AG is one of the largest healthcare providers in Germany. Its
corporate objective is high-quality medical care for everyone. Currently,
our Group counts 53 hospitals at 43 sites as well as 38 medical care
centres (MVZs) throughout Germany. We employ more than 39,000 persons. In
financial year 2011, more than 2.2 million patients were treated in the
Group's facilities. Further information is available at: 
www.rhoen-klinikum-ag.com


Dr. Kai G. Klinger
Head of Investor Relations

RHÖN-KLINIKUM AG
Schlossplatz 1
D-97616 Bad Neustadt a. d. Saale
Tel.:       +49 (0)9771-65.13 18
Fax:       +49 (0)9771-99.17 36
Mobil:   +49 (0)151-12 58 27 07
E-Mail:  kai.klinger@rhoen-klinikum-ag.com
web:      http://www.rhoen-klinikum-ag.com


Hans-Jürgen Heck      
RHÖN-KLINIKUM AG      
Head of Group Press and Public Relations    
Schlossplatz 1        
97616 Bad Neustadt a. d. Saale     
Tel. + 49 (9771) 65-1322       
Fax: + 49 (9771) 65-1820      
hans-juergen.heck@rhoen-klinikum-ag.com   


End of Corporate News

---------------------------------------------------------------------

09.02.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English                                                    
Company:     RHÖN-KLINIKUM AG                                           
             Schlossplatz 1                                             
             97616 Bad Neustadt a.d.Saale                               
             Germany                                                    
Phone:       +49 (0)9771 - 65-0                                         
Fax:         +49 (0)9771 - 97 467                                       
E-mail:      rka@rhoen-klinikum-ag.com                                  
Internet:    www.rhoen-klinikum-ag.com                                  
ISIN:        DE0007042301                                               
WKN:         704230                                                     
Listed:      Regulierter Markt in Frankfurt (Prime Standard), München;  
             Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart      
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
155953 09.02.2012                                                      

Anleihe im Fokus

7,75% p.a. - Rendite aus Familienhand

– Zeichnungsstart: 23. Mai – Börse Frankfurt
– Zeichnung ab 1.000 Euro
– Laufzeit 5 Jahre
– WKN: A1TNA7
– 100% Rückzahlungskurs

GBC-Fokusbox

Syzygy AG: Aktie kaufen

Die nach den ersten drei Monaten des laufenden Jahres von Syzygy präsentierten Zahlen liegen im Rahmen unserer Erwartungen. Angesichts unserer unveränderten Prognosen behalten wir das bisherige Kursziel von 5 € bei und erneuern das Rating KAUFEN.

Aktueller Webcast

Allianz SE

Analysts' conference call on 1Q 2013

15. Mai 2013

Aktuelle Research-Studie

Original-Research: InterCard AG Informationssysteme (von GBC AG): Kaufen InterCard AG Informationssysteme

21. Mai 2013